Will Tesla Stock Go Up In 2026?
EV giant Tesla (NASDAQ:TSLA) has, somewhat surprisingly, undershot the broader…
Sell
24
VHI.TO Quote, Financials, Valuation and Earnings
Last price:
$8.75
Seasonality move
:
0.97%
Day range:
$8.64 - $8.89
52-week range:
$8.50 - $14.64
Dividend yield:
0%
P/E ratio:
174.75x
P/S ratio:
5.14x
P/B ratio:
2.12x
Volume:
168.2K
Avg. volume:
210.6K
1-year change:
-24.61%
Market cap:
$554.8M
Revenue:
$68.6M
EPS (TTM):
$0.05
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
VHI.TO
Vitalhub Corp.
|
$28.2M | $0.04 | 49.85% | 270.35% | $15.20 |
|
COOL.CX
Core One Labs, Inc.
|
-- | -- | -- | -- | -- |
|
CURE.X.CX
Biocure Technology
|
-- | -- | -- | -- | -- |
|
HEAL.CX
|
-- | -- | -- | -- | -- |
|
NSHS.CX
NanoSphere Health Sciences, Inc.
|
-- | -- | -- | -- | -- |
|
WELL.TO
WELL Health Technologies Corp.
|
$368.1M | $0.10 | 99.35% | -77.88% | $7.65 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
VHI.TO
Vitalhub Corp.
|
$8.79 | $15.20 | $554.8M | 174.75x | $0.00 | 0% | 5.14x |
|
COOL.CX
Core One Labs, Inc.
|
$0.15 | -- | $6.8M | -- | $0.00 | 0% | 32.71x |
|
CURE.X.CX
Biocure Technology
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
HEAL.CX
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
NSHS.CX
NanoSphere Health Sciences, Inc.
|
$0.0250 | -- | $256.9K | 0.65x | $0.00 | 0% | -- |
|
WELL.TO
WELL Health Technologies Corp.
|
$4.01 | $7.65 | $1B | 41.90x | $0.00 | 0% | 0.84x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
VHI.TO
Vitalhub Corp.
|
0.61% | -1.255 | 0.23% | 1.79x |
|
COOL.CX
Core One Labs, Inc.
|
-- | 0.000 | -- | -- |
|
CURE.X.CX
Biocure Technology
|
-- | 0.000 | -- | -- |
|
HEAL.CX
|
-- | 0.000 | -- | -- |
|
NSHS.CX
NanoSphere Health Sciences, Inc.
|
-3.43% | 1.456 | 20.53% | 0.00x |
|
WELL.TO
WELL Health Technologies Corp.
|
42.5% | -0.072 | 42.92% | 0.83x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
VHI.TO
Vitalhub Corp.
|
$22.2M | $3M | 1.55% | 1.58% | 9.31% | $9.3M |
|
COOL.CX
Core One Labs, Inc.
|
-- | -- | -- | -- | -- | -- |
|
CURE.X.CX
Biocure Technology
|
-- | -- | -- | -- | -- | -- |
|
HEAL.CX
|
-- | -- | -- | -- | -- | -- |
|
NSHS.CX
NanoSphere Health Sciences, Inc.
|
-- | -$72.1K | -- | -- | -- | -$92.1K |
|
WELL.TO
WELL Health Technologies Corp.
|
$139.3M | $33.3M | -4.02% | -6.26% | 9.13% | $19.2M |
Vitalhub Corp. vs. Competitors
-
Which has Higher Returns VHI.TO or COOL.CX?
Core One Labs, Inc. has a net margin of -2.78% compared to Vitalhub Corp.'s net margin of --. Vitalhub Corp.'s return on equity of 1.58% beat Core One Labs, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital VHI.TOVitalhub Corp.69.39% -$0.01 $263.5M COOL.CXCore One Labs, Inc.-- -- -- -
What do Analysts Say About VHI.TO or COOL.CX?
Vitalhub Corp. has a consensus price target of $15.20, signalling upside risk potential of 72.98%. On the other hand Core One Labs, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Vitalhub Corp. has higher upside potential than Core One Labs, Inc., analysts believe Vitalhub Corp. is more attractive than Core One Labs, Inc..
Company Buy Ratings Hold Ratings Sell Ratings VHI.TOVitalhub Corp.5 0 0 COOL.CXCore One Labs, Inc.0 0 0 -
Is VHI.TO or COOL.CX More Risky?
Vitalhub Corp. has a beta of 0.643, which suggesting that the stock is 35.721% less volatile than S&P 500. In comparison Core One Labs, Inc. has a beta of 0.495, suggesting its less volatile than the S&P 500 by 50.458%.
-
Which is a Better Dividend Stock VHI.TO or COOL.CX?
Vitalhub Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Core One Labs, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Vitalhub Corp. pays -- of its earnings as a dividend. Core One Labs, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios VHI.TO or COOL.CX?
Vitalhub Corp. quarterly revenues are $32M, which are larger than Core One Labs, Inc. quarterly revenues of --. Vitalhub Corp.'s net income of -$890.3K is higher than Core One Labs, Inc.'s net income of --. Notably, Vitalhub Corp.'s price-to-earnings ratio is 174.75x while Core One Labs, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Vitalhub Corp. is 5.14x versus 32.71x for Core One Labs, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income VHI.TOVitalhub Corp.5.14x 174.75x $32M -$890.3K COOL.CXCore One Labs, Inc.32.71x -- -- --
-
Which has Higher Returns VHI.TO or CURE.X.CX?
Biocure Technology has a net margin of -2.78% compared to Vitalhub Corp.'s net margin of --. Vitalhub Corp.'s return on equity of 1.58% beat Biocure Technology's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital VHI.TOVitalhub Corp.69.39% -$0.01 $263.5M CURE.X.CXBiocure Technology-- -- -- -
What do Analysts Say About VHI.TO or CURE.X.CX?
Vitalhub Corp. has a consensus price target of $15.20, signalling upside risk potential of 72.98%. On the other hand Biocure Technology has an analysts' consensus of -- which suggests that it could fall by --. Given that Vitalhub Corp. has higher upside potential than Biocure Technology, analysts believe Vitalhub Corp. is more attractive than Biocure Technology.
Company Buy Ratings Hold Ratings Sell Ratings VHI.TOVitalhub Corp.5 0 0 CURE.X.CXBiocure Technology0 0 0 -
Is VHI.TO or CURE.X.CX More Risky?
Vitalhub Corp. has a beta of 0.643, which suggesting that the stock is 35.721% less volatile than S&P 500. In comparison Biocure Technology has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock VHI.TO or CURE.X.CX?
Vitalhub Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Biocure Technology offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Vitalhub Corp. pays -- of its earnings as a dividend. Biocure Technology pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios VHI.TO or CURE.X.CX?
Vitalhub Corp. quarterly revenues are $32M, which are larger than Biocure Technology quarterly revenues of --. Vitalhub Corp.'s net income of -$890.3K is higher than Biocure Technology's net income of --. Notably, Vitalhub Corp.'s price-to-earnings ratio is 174.75x while Biocure Technology's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Vitalhub Corp. is 5.14x versus -- for Biocure Technology. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income VHI.TOVitalhub Corp.5.14x 174.75x $32M -$890.3K CURE.X.CXBiocure Technology-- -- -- --
-
Which has Higher Returns VHI.TO or HEAL.CX?
has a net margin of -2.78% compared to Vitalhub Corp.'s net margin of --. Vitalhub Corp.'s return on equity of 1.58% beat 's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital VHI.TOVitalhub Corp.69.39% -$0.01 $263.5M HEAL.CX-- -- -- -
What do Analysts Say About VHI.TO or HEAL.CX?
Vitalhub Corp. has a consensus price target of $15.20, signalling upside risk potential of 72.98%. On the other hand has an analysts' consensus of -- which suggests that it could fall by --. Given that Vitalhub Corp. has higher upside potential than , analysts believe Vitalhub Corp. is more attractive than .
Company Buy Ratings Hold Ratings Sell Ratings VHI.TOVitalhub Corp.5 0 0 HEAL.CX0 0 0 -
Is VHI.TO or HEAL.CX More Risky?
Vitalhub Corp. has a beta of 0.643, which suggesting that the stock is 35.721% less volatile than S&P 500. In comparison has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock VHI.TO or HEAL.CX?
Vitalhub Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Vitalhub Corp. pays -- of its earnings as a dividend. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios VHI.TO or HEAL.CX?
Vitalhub Corp. quarterly revenues are $32M, which are larger than quarterly revenues of --. Vitalhub Corp.'s net income of -$890.3K is higher than 's net income of --. Notably, Vitalhub Corp.'s price-to-earnings ratio is 174.75x while 's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Vitalhub Corp. is 5.14x versus -- for . Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income VHI.TOVitalhub Corp.5.14x 174.75x $32M -$890.3K HEAL.CX-- -- -- --
-
Which has Higher Returns VHI.TO or NSHS.CX?
NanoSphere Health Sciences, Inc. has a net margin of -2.78% compared to Vitalhub Corp.'s net margin of --. Vitalhub Corp.'s return on equity of 1.58% beat NanoSphere Health Sciences, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital VHI.TOVitalhub Corp.69.39% -$0.01 $263.5M NSHS.CXNanoSphere Health Sciences, Inc.-- -$0.00 -$1.8M -
What do Analysts Say About VHI.TO or NSHS.CX?
Vitalhub Corp. has a consensus price target of $15.20, signalling upside risk potential of 72.98%. On the other hand NanoSphere Health Sciences, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Vitalhub Corp. has higher upside potential than NanoSphere Health Sciences, Inc., analysts believe Vitalhub Corp. is more attractive than NanoSphere Health Sciences, Inc..
Company Buy Ratings Hold Ratings Sell Ratings VHI.TOVitalhub Corp.5 0 0 NSHS.CXNanoSphere Health Sciences, Inc.0 0 0 -
Is VHI.TO or NSHS.CX More Risky?
Vitalhub Corp. has a beta of 0.643, which suggesting that the stock is 35.721% less volatile than S&P 500. In comparison NanoSphere Health Sciences, Inc. has a beta of 0.627, suggesting its less volatile than the S&P 500 by 37.292%.
-
Which is a Better Dividend Stock VHI.TO or NSHS.CX?
Vitalhub Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NanoSphere Health Sciences, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Vitalhub Corp. pays -- of its earnings as a dividend. NanoSphere Health Sciences, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios VHI.TO or NSHS.CX?
Vitalhub Corp. quarterly revenues are $32M, which are larger than NanoSphere Health Sciences, Inc. quarterly revenues of --. Vitalhub Corp.'s net income of -$890.3K is lower than NanoSphere Health Sciences, Inc.'s net income of -$13.1K. Notably, Vitalhub Corp.'s price-to-earnings ratio is 174.75x while NanoSphere Health Sciences, Inc.'s PE ratio is 0.65x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Vitalhub Corp. is 5.14x versus -- for NanoSphere Health Sciences, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income VHI.TOVitalhub Corp.5.14x 174.75x $32M -$890.3K NSHS.CXNanoSphere Health Sciences, Inc.-- 0.65x -- -$13.1K
-
Which has Higher Returns VHI.TO or WELL.TO?
WELL Health Technologies Corp. has a net margin of -2.78% compared to Vitalhub Corp.'s net margin of -0.73%. Vitalhub Corp.'s return on equity of 1.58% beat WELL Health Technologies Corp.'s return on equity of -6.26%.
Company Gross Margin Earnings Per Share Invested Capital VHI.TOVitalhub Corp.69.39% -$0.01 $263.5M WELL.TOWELL Health Technologies Corp.38.19% $0.02 $1.6B -
What do Analysts Say About VHI.TO or WELL.TO?
Vitalhub Corp. has a consensus price target of $15.20, signalling upside risk potential of 72.98%. On the other hand WELL Health Technologies Corp. has an analysts' consensus of $7.65 which suggests that it could grow by 90.77%. Given that WELL Health Technologies Corp. has higher upside potential than Vitalhub Corp., analysts believe WELL Health Technologies Corp. is more attractive than Vitalhub Corp..
Company Buy Ratings Hold Ratings Sell Ratings VHI.TOVitalhub Corp.5 0 0 WELL.TOWELL Health Technologies Corp.8 0 0 -
Is VHI.TO or WELL.TO More Risky?
Vitalhub Corp. has a beta of 0.643, which suggesting that the stock is 35.721% less volatile than S&P 500. In comparison WELL Health Technologies Corp. has a beta of 1.234, suggesting its more volatile than the S&P 500 by 23.424%.
-
Which is a Better Dividend Stock VHI.TO or WELL.TO?
Vitalhub Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. WELL Health Technologies Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Vitalhub Corp. pays -- of its earnings as a dividend. WELL Health Technologies Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios VHI.TO or WELL.TO?
Vitalhub Corp. quarterly revenues are $32M, which are smaller than WELL Health Technologies Corp. quarterly revenues of $364.6M. Vitalhub Corp.'s net income of -$890.3K is higher than WELL Health Technologies Corp.'s net income of -$2.7M. Notably, Vitalhub Corp.'s price-to-earnings ratio is 174.75x while WELL Health Technologies Corp.'s PE ratio is 41.90x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Vitalhub Corp. is 5.14x versus 0.84x for WELL Health Technologies Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income VHI.TOVitalhub Corp.5.14x 174.75x $32M -$890.3K WELL.TOWELL Health Technologies Corp.0.84x 41.90x $364.6M -$2.7M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
What Are the Best AI Power Stocks?
As the construction of AI infrastructure accelerates, the gap between…
Is IONQ The Best Quantum Stock to Buy?
Riding a wave of investor enthusiasm for the technology, quantum…
Stock Ideas
Sell
47
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 60x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
73
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 39x
Alerts
Buy
80
FEIM alert for Dec 15
Frequency Electronics, Inc. [FEIM] is down 3.51% over the past day.
Buy
57
MOD alert for Dec 15
Modine Manufacturing Co. [MOD] is up 1.79% over the past day.
Sell
42
OKLO alert for Dec 15
Oklo, Inc. [OKLO] is down 5.81% over the past day.
